BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16374080)

  • 21. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
    Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
    J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients.
    Vitellas KM; El-Dieb A; Vaswani KK; Bennett WF; Fromkes J; Ellison C; Bova JG
    AJR Am J Roentgenol; 2002 Aug; 179(2):409-16. PubMed ID: 12130442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment.
    Carlos RC; Hussain HK; Song JH; Francis IR
    AJR Am J Roentgenol; 2002 Jul; 179(1):87-92. PubMed ID: 12076911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
    Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced tumor detection in the presence of fatty liver disease: cell-specific contrast agents.
    Kreft BP; Tanimoto A; Baba Y; Zhao L; Finn JP; Stark DD
    J Magn Reson Imaging; 1994; 4(3):337-42. PubMed ID: 8061431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
    Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
    Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
    Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
    Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
    Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC
    Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New possibilities to study biliary tree and gallbladder: functional magnetic resonance cholangiography contrast-enhanced with mangafodipir trisodium (Mn DPDP)].
    Laurent V; Corby S; Barbary C; Kermarrec E; Béot S; Régent D
    J Radiol; 2007 Apr; 88(4):531-40. PubMed ID: 17464251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.
    Peña CS; Saini S; Baron RL; Hamm BA; Morana G; Caudana R; Giovagnoni A; Villa A; Carriero A; Mathieu D; Bourne MW; Kirchin MA; Pirovano G; Spinazzi A
    Korean J Radiol; 2001; 2(4):210-5. PubMed ID: 11754328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between liver function and liver parenchymal contrast enhancement on Gd-BOPTA-enhanced MR imaging in the hepatocyte phase.
    Zhao X; Huang M; Zhu Q; Wang T; Liu Q
    Magn Reson Imaging; 2015 Jul; 33(6):768-73. PubMed ID: 25842259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
    Wang QJ; Wang Y; Xu X; Xiao H; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F; Fraioli F; Catalano C; Napoli A; Danti M; Francone M; Venditti F; Nardis P; Passariello R
    Radiol Med; 2003; 106(1-2):87-93. PubMed ID: 12951555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors.
    Cai L; Yeh BM; Westphalen AC; Roberts J; Wang ZJ
    Abdom Radiol (NY); 2017 Mar; 42(3):842-850. PubMed ID: 27714420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
    Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
    Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.